Formulary

Click on article title to view & purchase. Articles are sorted by their publication date in reverse chronological order.

Xibrom.(FDA actions in brief)(Brief article)
February 01, 2006

Emend.(FDA actions in brief)(Brief article)
February 01, 2006

Vaprisol.(FDA actions in brief)(Brief article)
February 01, 2006

Climara Pro.(FDA actions in brief)(Brief article)
February 01, 2006

Revlimid.(FDA actions in brief)(Brief article)
February 01, 2006

Anecortave.(Selected literature)(Brief article)
February 01, 2006

Brimonidine/timolol.(Selected literature)(Brief article)
February 01, 2006

Travoprost/timolol.(Selected literature)(Brief article)
February 01, 2006

Verteporfin.(Selected literature)(Brief article)
February 01, 2006

Selected websites.(Drug Watch: A HEADS-UP ON PHARMACEUTICALS IN LATE-S...
February 01, 2006

Ophthalmic disorders.(Drug Watch: A HEADS-UP ON PHARMACEUTICALS IN LAT...
February 01, 2006

Medicare encourages more drug effectiveness information: need to limit...
February 01, 2006

Yaz.(Approvable designations)(Brief article)
February 01, 2006

Hepatitis C virus (HCV) protease inhibitor (SCH 503034, Schering-Ploug...
February 01, 2006

Peramivir injection (BioCryst Pharmaceutical) to treat influenza infec...
February 01, 2006

Favld.(Fast-track designations)(Brief article)
February 01, 2006

Phenoptin.(Fast-track designations)(Brief article)
February 01, 2006

Myodur.(Orphan drug designations)(Brief article)
February 01, 2006

Sutent: sunitinib.(New molecular entities)(gastrointestinal stromal tu...
February 01, 2006

Exubera: insulin human (rDNA origin) inhalation powder.(New formulatio...
February 01, 2006

Dalbavancin: a novel long-acting lipoglycopeptide antibiotic.(Focus on...
February 01, 2006

Influence of a urinary tract infection empiric treatment pathway on ph...
February 01, 2006

A growth hormone conversion program and patient outcomes at a not-for-...
February 01, 2006

Ranexa.(FDA actions in brief)(Brief article)
February 01, 2006